Sharma P, Ryves W J, Gordge P C, Evans A T, Shaun N, Thomas B, Parker P J, Evans F J
Department of Pharmacognosy, School of Pharmacy, University of London, UK.
J Pharm Pharmacol. 1995 Apr;47(4):297-306. doi: 10.1111/j.2042-7158.1995.tb05799.x.
We have separated a resiniferatoxin-stimulated histone-kinase activity from human neutrophils, elicited mouse macrophages and murine alveolar macrophages by hydroxyapatite chromatography. The assay conditions for resiniferatoxin kinase were optimized as part of this study and in the presence of phosphatidylserine but absence of Ca2+ the Ka for histone IIIs phosphorylation by resiniferatoxin was calculated as 16 nM. Using a phosphate gradient of 20-500 mM, peaks of protein kinase C activity could be washed from the hydroxyapatite column in 300 nM phosphate and resiniferatoxin kinase recovered in 500 mM phosphate. At the optimum concentration of 160 nM, the ability of resiniferatoxin to induce enzyme activity was compared with a range of phorbol esters all at the same concentration. These related compounds failed to activate resiniferatoxin kinase although they have previously been shown to activate protein kinase C isotypes. Similarly sn-1,2,-dioleoylglycerol and the potent irritant capsaicin at 30 microM failed to activate the kinase. A Scatchard analysis of [3H] phorbol dibutyrate binding produced a linear plot (Kd 41.6 nM; Bmax 11.6 fmol unit-1) and binding was inhibited by resiniferatoxin and 12-O-tetradecanoylphorbol-13-acetate (TPA), with resiniferatoxin 700 times more potent than TPA in this respect. A radiolabelled resiniferatoxin binding assay was also used to demonstrate specific binding of [3H]resiniferatoxin which could be inhibited by unlabelled compound. Resiniferatoxin kinase activity was shown to be distinct from the protein kinase C isotypes alpha, beta 1, gamma, delta and epsilon by means of immunological analysis and from the eta isotype, because that isotype was not stimulated by resiniferatoxin but was stimulated by TPA when a pseudosubstrate was used. In addition the resiniferatoxin-stimulated activity was inhibited in-vitro by the addition of Ca2+ (Ki 0.1-0.5 nM free Ca2+). Further purification of resiniferatoxin kinase by Superose chromatography indicated a major activity fraction of about 70-90 kDa. Thus resiniferatoxin kinase, isolated from human and mouse inflammatory cells is distinct from the known isotypes of protein kinase C and is a major resiniferatoxin receptor.
我们通过羟基磷灰石色谱法,从人中性粒细胞、诱导的小鼠巨噬细胞和鼠肺泡巨噬细胞中分离出了树脂毒素刺激的组蛋白激酶活性。作为本研究的一部分,我们对树脂毒素激酶的测定条件进行了优化,在磷脂酰丝氨酸存在但Ca2+不存在的情况下,计算出树脂毒素使组蛋白IIIs磷酸化的Ka为16 nM。使用20 - 500 mM的磷酸盐梯度,蛋白激酶C活性峰可在300 nM磷酸盐中从羟基磷灰石柱上洗脱下来,而树脂毒素激酶在500 mM磷酸盐中回收。在160 nM的最佳浓度下,将树脂毒素诱导酶活性的能力与一系列相同浓度的佛波酯进行了比较。这些相关化合物未能激活树脂毒素激酶,尽管它们此前已被证明可激活蛋白激酶C亚型。同样,30 microM的sn - 1,2 - 二油酰甘油和强效刺激剂辣椒素也未能激活该激酶。对[3H]佛波酯二丁酯结合进行的Scatchard分析产生了线性图(Kd 41.6 nM;Bmax 11.6 fmol单位-1),且结合受到树脂毒素和12 - O - 十四酰佛波醇-13 - 乙酸酯(TPA)的抑制,在这方面树脂毒素的效力比TPA强700倍。还使用放射性标记的树脂毒素结合测定法证明了[3H]树脂毒素的特异性结合,该结合可被未标记的化合物抑制。通过免疫分析表明,树脂毒素激酶活性与蛋白激酶C亚型α、β1、γ、δ和ε不同,也与η亚型不同,因为当使用假底物时,该亚型不受树脂毒素刺激,但受TPA刺激。此外,添加Ca2+(游离Ca2+的Ki为0.1 - 0.5 nM)可在体外抑制树脂毒素刺激的活性。通过Superose色谱法对树脂毒素激酶进行进一步纯化表明,主要活性部分约为70 - 90 kDa。因此,从人和小鼠炎性细胞中分离出的树脂毒素激酶与已知的蛋白激酶C亚型不同,是主要的树脂毒素受体。